Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:October 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:October 4, 2022Recruiting
Condition(s):Infiltrating Ductal CarcinomaLast Updated:June 18, 2012Completed
Condition(s):Neurofibromatosis Type 1; Precancerous ConditionLast Updated:April 4, 2014Terminated
Condition(s):Type B Aortic DissectionLast Updated:November 15, 2013Unknown status
Condition(s):Abdominal Aortic AneurysmLast Updated:July 28, 2017Completed
Condition(s):Brown Adipose TissueLast Updated:February 28, 2023Active, not recruiting
Condition(s):Lobular Breast CarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Cervical CancerLast Updated:February 1, 2006Unknown status
Condition(s):Adenocarcinomas of the Esophagogastric JunctionLast Updated:April 11, 2013Terminated
Condition(s):Giant Cell ArteritisLast Updated:February 28, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.